CIA
Capital Impact Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,605
| Closed | -$518K | – | 63 |
|
|
2024
Q1 | $518K | Sell |
7,605
-7,009
| -48% | -$478K | 0.67% | 66 |
|
|
2023
Q4 | $915K | Buy |
+14,614
| New | +$915K | 1.2% | 33 |
|
|
2023
Q3 | – | Sell |
-8,205
| Closed | -$461K | – | 125 |
|
|
2023
Q2 | $461K | Hold |
8,205
| – | – | 0.51% | 100 |
|
|
2023
Q1 | $371K | Buy |
+8,205
| New | +$371K | 0.46% | 106 |
|
|
2022
Q1 | – | Sell |
-3,470
| Closed | -$26K | – | 191 |
|
|
2021
Q4 | $26K | Buy |
+3,470
| New | +$26K | 0.02% | 97 |
|
|
2021
Q3 | – | Sell |
-45,440
| Closed | -$7.36M | – | 125 |
|
|
2021
Q2 | $7.36M | Buy |
+45,440
| New | +$7.36M | 2.37% | 3 |
|
|
2020
Q4 | – | Sell |
-70,000
| Closed | -$5.86M | – | 107 |
|
|
2020
Q3 | $5.86M | Buy |
+70,000
| New | +$5.86M | 1.74% | 10 |
|